-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Today's biggest pre-market stock movers: vTv Therapeutics, Aehr Test Systems, Unique Fabricating and more
Today's biggest pre-market stock movers: vTv Therapeutics, Aehr Test Systems, Unique Fabricating and more
Gainers
$vTv Therapeutics Inc(VTVT.US)$rose 21.47% to $2.15 in pre-market trading after the company disclosed results of multiple ascending dose studies and a development plan for HPP737, an oral PDE4 inhibitor for the treatment of psoriasis.
$Aehr Test Systems(AEHR.US)$ rose 21.4% to $14.30 in pre-market trading after the company reported better-than-expected Q1 results. The company also said it sees FY21 revenue of $50 million.
$Unique Fabricating Inc(UFAB.US)$ rose 19.4% to $3.01 in pre-market trading. The company’s Director Patrick W Cavanagh acquired a total of 13333 shares at an average price of $2.25.
$Progress Software Corp(PRGS.US)$ rose 15.3% to $53.30 in pre-market trading as the company reported better-than-expected results for its third quarter and raised FY21 guidance. The company also announced the acquisition of privately held Kemp for $258 million in cash.
$Minerva Neurosciences Inc(NERV.US)$ rose 13.6% to $2.09 in pre-market trading after gaining around 10% on Thursday.
$The Cross-Harbour(Holdings)(00032.HK)$ shares rose 8.1% to $0.7995 in pre-market trading after gaining around 4% on Thursday.
$Novo Integrated Sciences Inc(NVOS.US)$ rose 7.3% to $2.06 in pre-market trading after declining around 8% on Thursday.
$Argo Blockchain(ARBK.US)$ rose 6.6% to $17.86 in pre-market trading. The company’s shares jumped around 12% on Thursday after the company priced its IPO at $15 per ADS.
$Huaneng Power(HNP.US)$ rose 6.3% to $23.30 in pre-market trading.
$ReWalk Robotics Ltd(RWLK.US)$ rose 5.5% to $2.29 in pre-market trading after jumping over 21% on Thursday.
$ChemoCentryx Inc(CCXI.US)$ rose 5.2% to $18.90 in pre-market trading after climbing around 5% in the previous session. ChemoCentryx, last month, reported a Q3 loss of $0.56 per share.
Losers
$HELBIZ INC(HLBZ.US)$ shares fell 12.1% to $20.21 in pre-market trading. Helbiz recently announced a partnership with Drover AI to integrate its PathPilot safety technology onto Helbiz e-scooters.
$InnSuites Hospitality Trust(IHT.US)$ fell 12.1% to $4.50 in pre-market trading after jumping over 45% on Thursday.
$Four Seasons Education(FEDU.US)$ fell 11.9% to $0.7310 in pre-market trading. Four Seasons Education shares climbed 43% on Thursday after the company announced board authorization to repurchase up to $15 million.
$Onconova Therapeutics Inc(ONTX.US)$ shares fell 11% to $4.55 in pre-market trading after the company reported a proposed public offering of common stock.
$MEDIROM Healthcare Technologies, Inc.(MRM.US)$ fell 9.8% to $11.54 in pre-market trading. MEDIROM Healthcare Technologies shares surged over 73% on Thursday following news the company will buy ZACC Kabushiki Kaisha for $3.362 million.
$Amplitude Healthcare Acquisition Corp(AMHC.US)$ shares fell 7.4% to $13.30 in pre-market trading after climbing over 40% on Thursday. The company announced shareholders approved the business combination with Jasper Therapeutics.
$Senmiao Technology(AIHS.US)$ shares fell 7.4% to $0.7650 in pre-market trading after jumping over 16% on Thursday.
$Transcode Therapeutics(RNAZ.US)$ fell 6.7% to $3.75 in pre-market trading. TransCode Therapeutics shares surged 53% on Thursday after the company announced that preclinical research supporting its lead candidate, TTX-MC138, was published in Cancer Nanotechnology.
$Valneva SE(VALN.US)$ fell 6.5% to $31.69 in pre-market trading. Valneva said it commenced recruitment of adolescents in its pivotal Phase 3 trial for its inactivated COVID-19 vaccine candidate VLA2001 in the U.K.
$Nike(NKE.US)$ fell 4.7% to $152.13 in pre-market trading. Nike reported better-than-expected earnings for its first quarter, while sales missed expectations. The company also lowered its sales forecast for the full year.
Gainers
赢家
$vTv Therapeutics Inc(VTVT.US)$rose 21.47% to $2.15 in pre-market trading after the company disclosed results of multiple ascending dose studies and a development plan for HPP737, an oral PDE4 inhibitor for the treatment of psoriasis.
$Aehr Test Systems(AEHR.US)$ rose 21.4% to $14.30 in pre-market trading after the company reported better-than-expected Q1 results. The company also said it sees FY21 revenue of $50 million.
$Unique Fabricating Inc(UFAB.US)$ rose 19.4% to $3.01 in pre-market trading. The company’s Director Patrick W Cavanagh acquired a total of 13333 shares at an average price of $2.25.
$Progress Software Corp(PRGS.US)$ rose 15.3% to $53.30 in pre-market trading as the company reported better-than-expected results for its third quarter and raised FY21 guidance. The company also announced the acquisition of privately held Kemp for $258 million in cash.
$Minerva Neurosciences Inc(NERV.US)$ rose 13.6% to $2.09 in pre-market trading after gaining around 10% on Thursday.
$The Cross-Harbour(Holdings)(00032.HK)$ shares rose 8.1% to $0.7995 in pre-market trading after gaining around 4% on Thursday.
$Novo Integrated Sciences Inc(NVOS.US)$ rose 7.3% to $2.06 in pre-market trading after declining around 8% on Thursday.
$Argo Blockchain(ARBK.US)$ rose 6.6% to $17.86 in pre-market trading. The company’s shares jumped around 12% on Thursday after the company priced its IPO at $15 per ADS.
$Huaneng Power(HNP.US)$ rose 6.3% to $23.30 in pre-market trading.
$ReWalk Robotics Ltd(RWLK.US)$ rose 5.5% to $2.29 in pre-market trading after jumping over 21% on Thursday.
$ChemoCentryx Inc(CCXI.US)$ rose 5.2% to $18.90 in pre-market trading after climbing around 5% in the previous session. ChemoCentryx, last month, reported a Q3 loss of $0.56 per share.
$VTV治疗公司(VTVT.US)$在盘前交易中,该公司股价上涨21.47%,至2.15美元,此前该公司披露了多次递增剂量研究的结果,以及治疗牛皮癣的口服PDE4抑制剂HPP737的开发计划。
$Aehr测试系统(AEHR.US)$在盘前交易中,该公司股价上涨21.4%,至14.30美元,此前该公司公布的第一季度业绩好于预期。该公司还表示,预计21财年收入将达到5000万美元。
$Unique Facing Inc.(UFAB.US)$在盘前交易中,该股上涨19.4%,至3.01美元。该公司旗下董事帕特里克·W·卡瓦纳以2.25美元的平均价格收购了总计13333股。
$Progress Software Corp(PRGS.US)$在盘前交易中,该公司股价上涨15.3%,至53.30美元,该公司公布的第三季度业绩好于预期,并上调了21财年业绩指引。该公司还宣布以2.58亿美元现金收购私人持股的Kemp。
$Minerva神经科学公司(NERV.US)$ 在周四上涨约10%后,该股在盘前交易中上涨13.6%,至2.09美元。
$香港海底隧道(控股)(00032.HK)$ 股价在周四上涨约4%后,在盘前交易中上涨8.1%,至0.7995美元。
$Novo集成科学公司(NVOS.US)$在周四下跌约8%后,该股在盘前交易中上涨7.3%,至2.06美元。
$Argo区块链(ARBK.US)$在盘前交易中,该股上涨6.6%,至17.86美元。新浪美国存托股份将首次公开募股定价为每股15美元,公司股价周四上涨约12%。
$华能电力(HNP.US)$ 在盘前交易中,该公司股价上涨6.3%,至23.30美元。
$ReWalk Robotics Ltd(RWLK.US)$在周四跃升逾21%后,该股在盘前交易中上涨5.5%,至2.29美元。
$ChemoCentryx Inc.(CCXI.US)$在盘前交易中,该公司股价上涨5.2%,至18.90美元,前一交易日攀升约5%。上个月,ChemoCentryx公布第三季度每股亏损0.56美元。
Losers
失败者
$HELBIZ INC(HLBZ.US)$ shares fell 12.1% to $20.21 in pre-market trading. Helbiz recently announced a partnership with Drover AI to integrate its PathPilot safety technology onto Helbiz e-scooters.
$InnSuites Hospitality Trust(IHT.US)$ fell 12.1% to $4.50 in pre-market trading after jumping over 45% on Thursday.
$Four Seasons Education(FEDU.US)$ fell 11.9% to $0.7310 in pre-market trading. Four Seasons Education shares climbed 43% on Thursday after the company announced board authorization to repurchase up to $15 million.
$Onconova Therapeutics Inc(ONTX.US)$ shares fell 11% to $4.55 in pre-market trading after the company reported a proposed public offering of common stock.
$MEDIROM Healthcare Technologies, Inc.(MRM.US)$ fell 9.8% to $11.54 in pre-market trading. MEDIROM Healthcare Technologies shares surged over 73% on Thursday following news the company will buy ZACC Kabushiki Kaisha for $3.362 million.
$Amplitude Healthcare Acquisition Corp(AMHC.US)$ shares fell 7.4% to $13.30 in pre-market trading after climbing over 40% on Thursday. The company announced shareholders approved the business combination with Jasper Therapeutics.
$Senmiao Technology(AIHS.US)$ shares fell 7.4% to $0.7650 in pre-market trading after jumping over 16% on Thursday.
$Transcode Therapeutics(RNAZ.US)$ fell 6.7% to $3.75 in pre-market trading. TransCode Therapeutics shares surged 53% on Thursday after the company announced that preclinical research supporting its lead candidate, TTX-MC138, was published in Cancer Nanotechnology.
$Valneva SE(VALN.US)$ fell 6.5% to $31.69 in pre-market trading. Valneva said it commenced recruitment of adolescents in its pivotal Phase 3 trial for its inactivated COVID-19 vaccine candidate VLA2001 in the U.K.
$Nike(NKE.US)$ fell 4.7% to $152.13 in pre-market trading. Nike reported better-than-expected earnings for its first quarter, while sales missed expectations. The company also lowered its sales forecast for the full year.
$HELBIZ Inc.(HLBZ.US)$在盘前交易中,该公司股价下跌12.1%,至20.21美元。Helbiz最近宣布与Drover AI合作,将其PathPilot安全技术集成到Helbiz电动滑板车上。
$InnSuites酒店信托基金(IHT.US)$ 在周四跃升逾45%后,该股在盘前交易中下跌12.1%,至4.50美元。
$四季教育(FEDU美国)$在盘前交易中,该公司股价下跌11.9%,至0.7310美元。四季教育股价周四攀升43%,此前该公司宣布董事会授权回购至多1,500万美元。
$Onconova Treateutics Inc.(ONTX.US)$在盘前交易中,该公司股价下跌11%,至4.55美元,此前该公司公布拟公开发行普通股。
$MEDIROM Healthcare Technologies,Inc.(MRM.US)$在盘前交易中,该公司股价下跌9.8%,至11.54美元。周四,在MEDIROM Healthcare Technologies将以336.2万美元收购ZACC Kabushiki Kaisha的消息传出后,该公司股价飙升逾73%。
$Amplance Healthcare Acquisition Corp(AMHC.US)$在周四攀升逾40%后,苹果股价在盘前交易中下跌7.4%,至13.30美元。该公司宣布,股东批准了与Jasper治疗公司的业务合并。
$爱鸿森(AIHS.US)$该公司股价在周四跃升逾16%后,在盘前交易中下跌7.4%,至0.7650美元。
$转码治疗公司(RNAZ.US)$ 在盘前交易中下跌6.7%,至3.75美元。周四,Transcode治疗公司股价飙升53%,此前该公司宣布,支持其主要候选药物TTX-MC138的临床前研究发表在《癌症纳米技术》杂志上。
$Valneva SE(VALN.US)$ 在盘前交易中下跌6.5%,至31.69美元。Valneva说,它在英国开始为其灭活新冠肺炎候选疫苗VLA2001招募青少年,这是其关键的第三阶段试验。
$耐克(NKE.US)$在盘前交易中,该公司股价下跌4.7%,至152.13美元。耐克公布的第一季度收益好于预期,而销售额低于预期。该公司还下调了全年的销售预期。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧